₹ (%)
- NSE
- BSE
Overview
- BSE Code 538965
- NSE Symbol
- ISIN Demat INE858L01010
- Book Value (₹) 34.11
- Face Value (₹) 10.00
- Market Cap (₹ Cr.) 60.81
- P/E (TTM) 202.70
- EPS (TTM) 0.30
- Div Yield (%) 0.00
Performance
About Concord Drugs Ltd
CONCORD DRUGS LIMITED is a public limited company created and deployed in 1995, is among the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small volume parenterals, Dry powder ) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets.
State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality.
The company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide our customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.
The company operates a state of the art, cGMP contract manufacturing Formulation-Fill-Finish facility, providing comprehensive pharmaceutical development and manufacturing services for drug products.
The company has two manufacturing facilities built to comply with standards stipulated by Regulatory bodies.
Founded | : 1995 |
Chairman | : S Nagi Reddy |
Managing Director | : S Nagi Reddy |
Address | : Survey No 249 Brahmanapally V, Hayathnagar M, Ranga Reddy, Telangana, 501511, |
- PAN Card
- Cancelled Cheque
- Latest 6 month Bank Statement (Only for Derivatives Trading)